UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia

Leukemia, 2015-05, Vol.29 (5), p.999-1003

2015

Volltextzugriff (PDF)

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

Leukemia, 2020-04, Vol.34 (4), p.966-984

2020

Volltextzugriff (PDF)

Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - A Europe Against Cancer Program

Leukemia, 2003-12, Vol.17 (12), p.2318-2357

2003

Volltextzugriff (PDF)

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program

Leukemia, 2003-12, Vol.17 (12), p.2474-2486

2003

Volltextzugriff (PDF)

Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations

Leukemia, 2006-06, Vol.20 (6), p.1103-1108

2006

Volltextzugriff (PDF)

Rationale for the recommendations for harmonizing current methodology for detecting BCR-ABL transcripts in patients with chronic myeloid leukaemia

Leukemia, 2006-11, Vol.20 (11), p.1925-1930

2006

Volltextzugriff (PDF)

Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapy

Haematologica (Roma), 2008-06, Vol.93 (6), p.921-924

2008

Volltextzugriff (PDF)

The molecular anatomy of the FIP1L1-PDGFRA fusion gene

Leukemia, 2009-02, Vol.23 (2), p.271-278

2009

Volltextzugriff (PDF)

Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts

Leukemia, 2002-06, Vol.16 (6), p.1176-1181

2002

Volltextzugriff (PDF)

Retrospective comparison of qualitative and quantitative reverse transcriptase polymerase chain reaction in diagnosing and monitoring the ALL1-AF4 fusion transcript in patients with acute lymphoblastic leukaemia

Leukemia, 2004-11, Vol.18 (11), p.1824-1830

2004

Volltextzugriff (PDF)

Significant Correlation Between the Degree of WT1 Expression and the International Prognostic Scoring System Score in Patients With Myelodysplastic Syndromes

Journal of clinical oncology, 2003-05, Vol.21 (10), p.1988-1995

2003

Volltextzugriff (PDF)

Neutrophilic-chronic myeloid leukemia : A distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction)

Blood, 1996-10, Vol.88 (7), p.2410-2414

1996

Volltextzugriff (PDF)

Molecular evidence of minimal residual disease after treatment for leukaemia and lymphoma: an updated meeting report and review

Leukemia, 1993-08, Vol.7 (8), p.1302-1314

1993

Volltextzugriff (PDF)

Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia

Blood, 2000-01, Vol.95 (2), p.651-659

2000

Volltextzugriff (PDF)

The common TEL/AML1 rearrangement does not represent a frequent event in acute lymphoblastic leukaemia occurring in children with Down syndrome

Leukemia, 1997-06, Vol.11 (6), p.820-821

1997

Volltextzugriff (PDF)

Quantification of BCR-ABL transcripts in CML patients in cytogenetic remission after interferon-α-based therapy

Bone marrow transplantation (Basingstoke), 2000-04, Vol.25 (7), p.729-736

2000

Volltextzugriff (PDF)

Minimal residual disease detection in human leukemias: biologic and clinical significance

Acta haematologica polonica, 1995, Vol.26 (2 Suppl 1), p.19

Saglio, G

1995

Volltextzugriff (PDF)

Analysis of microsatellite instability in chronic lymphoproliferative disorders

Annals of hematology, 1996-02, Vol.72 (2), p.67-71

1996

Volltextzugriff (PDF)

Kaposi's sarcoma‐associated herpesvirus DNA sequences in AIDS‐related and AIDS‐unrelated lymphomatous effusions

British journal of haematology, 1996-09, Vol.94 (3), p.533-543

1996

Volltextzugriff (PDF)

Minimal residual disease in B-lymphoproliferative disorders by PCR detection of immunoglobulin heavy chain gene recombination

Scandinavian journal of clinical and laboratory investigation, 1997, Vol.57 (6), p.541-547

1997

Volltextzugriff (PDF)

p53 Gene inactivation in acute lymphoblastic leukemia of B cell lineage associates with chromosomal breakpoints at 11q23 and 8q24

Leukemia, 1995-06, Vol.9 (6), p.955-959

1995

Volltextzugriff (PDF)

Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease

Leukemia, 1999-12, Vol.13 (12), p.1901-1928

1999

Volltextzugriff (PDF)

Genetic analysis of p53 and RB1 tumor-suppressor genes in blast crisis of chronic myeloid leukemia

Annals of hematology, 1994, Vol.68 (1), p.3-7

1994

Volltextzugriff (PDF)

Multiple Genetic Lesions in Acquired Immunodeficiency Syndrome-Related Non-Hodgkin’s Lymphoma

Blood, 1993-01, Vol.81 (1), p.166-176

1993

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Aktive Filter

ThemaPolymerase Chain Reaction

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(79)

Sprache

Englisch
(78)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(77)
Life Sciences & Biomedicine
(61)
Science & Technology
(61)
Biological And Medical Sciences
(47)
Medical Sciences
(46)
Hematology
(44)
Base Sequence
(32)
Hematologic And Hematopoietic Diseases
(31)
Molecular Sequence Data
(31)
Oncology
(29)
Male
(28)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(27)
Female
(25)
Adult
(23)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Genetics
(22)
Middle Aged
(20)
Mutation
(17)
Fusion Proteins, Bcr-Abl - Genetics
(16)
Adolescent
(12)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale

Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - A Europe Against Cancer Program

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program

Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations

Rationale for the recommendations for harmonizing current methodology for detecting BCR-ABL transcripts in patients with chronic myeloid leukaemia

Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapy

The molecular anatomy of the FIP1L1-PDGFRA fusion gene

Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts

Retrospective comparison of qualitative and quantitative reverse transcriptase polymerase chain reaction in diagnosing and monitoring the ALL1-AF4 fusion transcript in patients with acute lymphoblastic leukaemia

Significant Correlation Between the Degree of WT1 Expression and the International Prognostic Scoring System Score in Patients With Myelodysplastic Syndromes

Neutrophilic-chronic myeloid leukemia : A distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction)

Molecular evidence of minimal residual disease after treatment for leukaemia and lymphoma: an updated meeting report and review

Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia

The common TEL/AML1 rearrangement does not represent a frequent event in acute lymphoblastic leukaemia occurring in children with Down syndrome

Quantification of BCR-ABL transcripts in CML patients in cytogenetic remission after interferon-α-based therapy

Minimal residual disease detection in human leukemias: biologic and clinical significance

Analysis of microsatellite instability in chronic lymphoproliferative disorders

Kaposi's sarcoma‐associated herpesvirus DNA sequences in AIDS‐related and AIDS‐unrelated lymphomatous effusions

Minimal residual disease in B-lymphoproliferative disorders by PCR detection of immunoglobulin heavy chain gene recombination

p53 Gene inactivation in acute lymphoblastic leukemia of B cell lineage associates with chromosomal breakpoints at 11q23 and 8q24

Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease

Genetic analysis of p53 and RB1 tumor-suppressor genes in blast crisis of chronic myeloid leukemia

Multiple Genetic Lesions in Acquired Immunodeficiency Syndrome-Related Non-Hodgkin’s Lymphoma

Aktive Filter

Suchergebnisse filtern